The erythrocyte receptors for S-fimbriated Escherichia coli, which causes sepsis and meningitis in newborn infants, were investigated. Neuraminidase and trypsin treatments of erythrocytes abolished the hemagglutination ability of the bacteria. To identify the receptor glycoproteins, we separated erythrocyte membrane proteins by gel electrophoresis, blotted them to nitrocellulose, and incubated them with 1251-labeled bacteria.
NeuAcx2-3GalP1-3GalNAc sequence in asialoglycophorins, restored bacterial hemagglutination. These results indicated that the major erythrocyte receptor for S-fimbriated E. coli is the NeuAca2-3Gal1-3GalNAc sequence of the 0-linked oligosaccharide chains of glycophorin A.
The ability of bacteria to adhere to host epithelial cells is regarded as a prerequisite for the establishment of infectious diseases (2) such as pyelonephritis (34) and diarrhea (11) caused by Escherichia coli. The adhesion of E. coli and other gram-negative bacteria takes place through the binding of bacterial fimbriae to specific receptors on the host cell surface (2, 15) . Most of the few bacterial receptors identified at the molecular level are carbohydrates. Carbohydrate structures considered to be cell surface binding sites for E. coli include the Galal-4Gal sequence of P blood group antigens (14, 20) , a-mannosides (25) , and terminal Nacetylglucosamine residues (38) . Although there is evidence for the glycoprotein nature of the receptors for mannosebinding E. coli (7) and for Mycoplasma pneumoniae (22) , all the carbohydrate receptors for bacteria ascribed to single molecular species have been glycolipids (13, 14, 20) .
We have recently shown that several E. coli strains bind to sialic acid-containing structures on human erythrocytes (28) . Hemagglutination inhibition studies with isolated sialyloligosaccharides indicated that this binding activity has specificity for the NeuAcot2-3Gal sequence. The bacterial components mediating the binding to sialylgalactosides were identified as a novel type of fimbriae, designated as S fimbriae (16) . S fimbriae were recently shown to be associated with E. coli serotype 018:K1:H7, which causes meningitis and septicemia in newborn infants, suggesting that S fimbriae may have a pathogenic role in these infections (17) . However, the molecular nature of the host cell sialoglycoconjugates recognized by S fimbriae is not known.
To identify the pathophysiological receptors for S fimbriae, knowledge of the molecular nature of these receptors and methods of investigation are needed. In the present study, the erythrocyte receptor for S-fimbriated E. coli was identified, by a novel application of the protein blot overlay method, as glycophorin A, the MN sialoglycoprotein. The bacterium-binding site in glycophorin A was found to be the 0-linked NeuAcot2-3GalP1-3GalNAc sequence.
MATERIALS AND METHODS Abbreviations. The abbreviations used in this paper are as follows: Gal, D-galactose; GalNAc, N-acetyl-D-galactosamine; GlcNAc, N-acetyl-D-glucosamine; NeuAc, Nacetylneuraminic acid; Pi/NaCl, 10 mM sodium phosphate-0.15 M NaCl (pH 7.4).
Materials. Trypsin (type XIII, tolylsulfonyl phenylalanyl chloromethyl ketone treated), fetuin (type IV), and methyl a-D-mannose were from Sigma Chemical Co., St. Louis, Mo. Endo-p-galactosidase was from Seikagaku Kogyo, Tokyo, Japan, and wheat germ agglutinin was from Pharmacia, Uppsala, Sweden. lodo-Beads were from Pierce Chemical Co., Rockford, Ill., and polyvinylpyrrolidone K 30 was from Fluka, Buchs, Switzerland. Titertek flat-bottomed polyvinyl chloride immunoassay microplates (highly activated) were from Flow Laboratories, Ayrshire, Scotland. Nitrocellulose membrane (type HAWP; pore size, 0.45 ,um) was from Millipore Corp., Molsheim, France. XAR-5 X-ray film was from Eastman Kodak Co., Rochester, N.Y. ax-Acid glycoprotein was kindly provided by G. Myllyla (Finnish Red Cross Blood Transfusion Service). Sialyloligosaccharides were purified from human urine (26, 27) and bovine colostrum (28) as described before. NeuAca2-3Gal3l-3GalNAc was liberated from the corresponding 1-phosphate (27) by phosphatase treatment, followed by purification on a column of AG 1-X2 (26 (28) . Hemagglutination titers were expressed as the reciprocal of the lowest dilution of bacteria causing.hemagglutination after 5 min.
Enzyme treatments of erythrocytes. Trypsin treatment of erythrocytes was carried out as described before (4) with trypsin concentrations of 0.2 and 1.0 mg/ml. Endo-pgalactosidase treatment (39) and NaIO4 treatment (12) were performed as previously described. Neuraminidase treatment of erythrocytes and subsequent resialylation with purified sialyltransferases were carried out as described before (31) .
Protein blot overlay studies. Erythrocyte membranes were prepared as described before (6) . Sodium dodecyl sulfatepolyacrylamide gel electrophoresis was performed in slab gels (9% acrylamide, 1.5 mm thick) as described by Laemmli (18) . After electrophoresis the gels were equilibrated for 30 min in 25 mM Tris-192 mM glycine buffer containing 20% (vol/vol) methanol, and the proteins were transferred from the gels to a nitrocellulose sheet (37) in the same buffer by using an electric current of 140 mA for 16 h in the cold. The nitrocellulose sheet was washed with Pi/NaCl and stored frozen at -20°C. Proteins were stained with amido black (37) . Since glycophorin A did not stain, it was visualized by being overlaid with 125I-labeled wheat germ agglutinin after incubation of the blot in 2% (wt/vol) polyvinylpyrrolidone (1) .
For bacterium-binding studies, the nitrocellulose sheet was cut into strips and incubated in Pi/NaCl containing 3% (wt/vol) bovine serum albumin at 37°C for 1 h. The strips were overlaid with radiolabeled bacteria (106 cpm/ml) in Pi/NaCl containing 3% (wt/vol) bovine serum albumin and 0.1 M methyl ot-D-mannose (1 ml for a 1-by 12-cm strip) and incubated without shaking in a humid atmosphere at 4°C for 3 h. The strips were washed six times with cold Pi/NaCl for 5 min each time on a tilting table, dried, and exposed to XAR-5 X-ray film by using an intensifying screen at -70°C for 6 to 16 h. For desialylation experiments, the strips were washed once after albumin treatment with 50 mM sodium acetate buffer (pH 5.5) containing 5 mM CaCl2 and 0.1% (wt/vol) bovine serum albumin and incubated in the same buffer with or without Vibrio cholerae neuraminidase (50 mU/ml) at 37°C for 16 h. The strips were washed three times with Pi/NaCl for 5 min each time and overlaid with 125I-labeled bacteria as described above.
Bacterium-binding assay in microwelis. Purified glycophorin AM or AN was adsorbed to polyvinyl chloride microtiter wells by incubation at various concentrations in 50 ,l of Pi/NaCl at 23°C for 2 h. The wells were washed four times with 200 pI of Pi/NaCl and incubated with 200 pu1 of Pi/NaCl containing 0.1% (wt/vol) bovine serum albumin at 23°C for 30 min. After the wells were emptied, 125I-labeled bacteria (about 105 cpm per well) were added in 50 RI of Pi/NaCl containing 0.1% (wt/vol) bovine serum albumin with or without inhibitors and incubated at 4°C for 16 h. The wells were washed six times with 200 pu1 of cold Pi/NaCl and cut from the plate for radioactivity determination in a gamma scintillation spectrometer.
RESULTS
Trypsin and endo-,3-galactosidase treatments of erythrocytes. In agreement with earlier results (28) , neuraminidase treatment of erythrocytes destroyed the bacterial receptors (Table 1) . Mild periodate treatment of erythrocytes, which oxidizes mainly the glycerol side chain of sialic acid (12) , also abolished bacterial hemagglutination (Table 1) . Trypsin treatment of erythrocytes either markedly decreased bacterial hemagglutination or abolished it, depending on the trypsin concentration (Table 1) . Trypsin is known to specifically cleave the N-terminal part of glycophorin A (4). Thus, the trypsin sensitivity of the erythrocyte receptors for Sfimbriated E. coli indicated the proteinaceous nature of these molecules and also suggested that the major receptor was glycophorin A. Bacterial hemagglutination was not affected by endo-p-galactosidase treatment of erythrocytes (Table 1) , which is known to cleave the polylactosamine chains of band 3, band 4.5, and poly(glycosyl)ceramides (8 (Fig. 1) . Purified glycophorin A bound the bacteria in a similar fashion (Fig.  1 (Fig. 2) . The binding was inhibited by the sialoglycoproteins fetuin and a1-acid glycoprotein, as well as by the isolated sialyloligosaccharides (Fig. 3) , indicating that the binding was specific.
No difference was observd in bacterial binding between glycophorins AM and AN.
In agreement with the results obtained by hemagglutination inhibition (28) , oligosaccharides containing the NeuAca2-3Gal sequence were potent inhibitors of bacterial binding, whereas corresponding oligosaccharides containing the NeuAca2-6Gal or NeuAcoa2-8NeuAca2-3Gal sequences did not induce inhibition at the concentrations used; free sialic acid or lactose also did not induce inhibition ( Table 2 ). The three different sialyloligosaccharides with the NeuAca2-3Gal p1-4 sequence were equally good inhibitors, irrespective of (Table 2) . However, the oligosaccharide with the NeuAcao2-3GalP1-3GalNAc sequence and its derivative sialylated at C-6 of GalNAc, which are identical to the 0-linked sugar chains of glycophorin A (21, 35) , were about twofold better at inhibition than were the other oligosaccharides with the NeuAcot2-3Gal sequence ( Table 2 ). The relative inhibitory effects of these two oligosaccharides were also similar in the hemagglutination inhibition assay (results not shown).
Binding of bacteria to resialylated erythrocytes. To further demonstrate that the 0-linked NeuAcot2-3Gal,B1-3GalNAc sequence of glycophorin A is in fact the major erythrocyte receptor for S-fimbriated E. coli, we enzymatically modified human erythrocytes to contain one single sialyloligosaccharide sequence. Sialic acid was removed from the erythrocytes by neuraminidase treatment, and the asialoerythrocytes were subsequently resialylated with one of four highly purified sialyltransferases as previously described (31) . Only GalP1-3GalNAc ox2-3 sialyltransferase, which specifically transfers sialic acid to the GalIl-3GalNAc sequence (30) , restored bacterial hemagglutination ( Table 3) . The majority (85 to 90%) of sialic acid incorporated by this enzyme into asialoerythrocytes is found in glycophorins A and B (29) . Thus, these results confirmed that the primary erythrocyte receptor for S-fimbriated E. coli is the 0-linked NeuAcot2-3GalI1-3GalNAc sequence of glycophorin A.
The ability of bacteria to agglutinate the derivatized erythrocytes was dependent on the amount of sialic acid incorporated, with a threshold limit between 46 and 89 nmol of sialic acid per ml of packed cells (Table 3) . It should be noted that the 0-linked oligosaccharides occur on the erythrocyte surface at a higher concentration than do the N-linked chains containing the Gal,B1-4GlcNAc termini. The incorporation of sialic acid into the latter structures remained lower than the threshold amount for bacterial hemagglutination (Table 3 
DISCUSSION
Although the role of glycolipids as the host cell receptors for bacterial adhesion has been much emphasized recently (13) , the present study shows that protein-bound saccharides Glycophorin A is one of the best-characterized membrane proteins. Its amino acid sequence has been determined (36) , and it is known to contain an average of 15 0-linked sugar chains (36) and 1 N-linked chain of the complex biantennary type (40) . The structure of most of the 0-linked chains has been identified as NeuAcot2-3Galr3l-3(NeuAcot2-6)GalNAc (21, 35) . The binding site for S-fimbriated E. coli in glycophorin A is the NeuAc cx2-3Galr31-3GalNAc sequence of the 0-linked chains, as revealed by the following two findings. First, Galpl-3GalNAca2-3 sialyltransferase, which forms the 0-linked NeuAccx2-3GalP1-3GalNAc sequence in asialoglycophorins (29) restored the hemagglutination ability of the bacteria. Second, isolated sialyloligosaccharides containing this sugar chain were potent inhibitors of bacterial binding to glycophorin A, whereas oligosaccharides which only shared the NeuAcox2-3Gal sequence with this structure were somewhat less effective. The ox2-6-bound sialic acid residue in the 0-linked chains does not seem to contribute to bacterial binding, since the free oligosaccharides containing the NeuAco2-3GalP1-3GalNAc and NeuAcco2-3Galp1-3(NeuAcot2-6)GalNAc sequences were equally effective inhibitors. This result also suggests that the GalNAc residue is recognized only partially by the bacteria, since its substitution at the C-6 position did not affect the inhibitory effect of the oligosaccharides. On the other hand, the importance of the terminal ax2-3-linked sialic acid moiety in bacterial binding is indicated by the findings that the removal of sialic acid by neuraminidase treatment and even the removal of its glycerol side chain by mild periodate treatment totally abolished bacterial hemagglutination. (Fig. 3) . In this respect, S fimbriae are similar to other lectins, such as the galactose-specific lectin of mammalian liver, for which it has been shown that the ability of glycoproteins to bind to the lectin increases exponentially as the number of appropriate sugars attached to the protein increases (33) .
The minor sialoglycoproteins of the erythrocyte membrane (glycophorins B and C) appear to carry 0-linked sialyloligosaccharides similar to those of glycophorin A (9) . Our experiments with erythrocyte membranes (Fig. 1) did not reveal bacterial binding to these minor sialoglycoproteins, a result which may have been due to their lower concentrations in the erythrocyte membrane as compared with that of glycophorin A (9) . The fact that a1-acid glycoprotein, fetuin, and isolated sialyloligosaccharides were potent inhibitors of bacterial binding to glycophorin A (Fig. 3 (19) . However, no binding of radiolabeled S-fimbriated E. coli to thin-layer chromatograms of these gangliosides (13) could be detected (J. Parkkinen 
